Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Czech Republic

Sanofi-Aventis Leads Foreign Charge Into Generics Sector

March 2006 | FDI Alert

French drug major Sanofi-Aventis has bought a 24.9% stake in Czech generic firm Zentiva for EUR430mn (US$517mn) to further penetrate markets in Eastern and Central

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries